New pain block could cut opioid use in super obese surgery patients
NCT ID NCT06377605
First seen Nov 21, 2025 · Last updated Jun 21, 2026 · Updated 26 times
Summary
This completed trial tested whether a nerve block called erector spinae plane block (ESPB) can reduce pain and opioid use in super obese patients (BMI over 50) after laparoscopic bariatric surgery. Sixty participants received either the ESPB or standard local anesthetic at the incision sites. The goal was to see if ESPB provides better pain control and lowers the need for opioids, which carry risks like breathing problems in this population.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kasr Al Ainy Hospitals
Cairo, Egypt
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
erector spinae plane block (ESPB) with local anesthetic
What this could lead to
If effective, this nerve block could provide a safer pain management option for super obese patients after bariatric surgery, reducing reliance on opioids.
What could go wrong
This is a small, completed trial without a phase designation, so results may not apply broadly. The block may be harder to perform in super obese patients, and its effectiveness is still uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.